PREDICTION OF RESIDUAL RETROPERITONEAL MASS HISTOLOGY AFTER CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - MULTIVARIATE-ANALYSIS OF INDIVIDUAL PATIENT DATA FROM 6 STUDY-GROUPS
Ew. Steyerberg et al., PREDICTION OF RESIDUAL RETROPERITONEAL MASS HISTOLOGY AFTER CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - MULTIVARIATE-ANALYSIS OF INDIVIDUAL PATIENT DATA FROM 6 STUDY-GROUPS, Journal of clinical oncology, 13(5), 1995, pp. 1177-1187
Purpose: To develop a statistical model that predicts the histology (n
ecrosis, mature teratoma, or cancer) after chemotherapy for metastatic
nonseminomatous germ cell tumor (NSGCT). Patients and Methods: An int
ernational data was collected comprising individual patient data from
six study groups. Logistic regression analysis was used to estimate th
e probability of necrosis and the ratio of cancer and mature teratoma.
Results: Of 556 patients, 250 (45%) had necrosis at resection, 236 (4
2%) had mature teratoma, and 70 (13%) had cancer. Predictors of necros
is were the absence fo teratoma elements in the primary tumor, prechem
otherapy normal alfa-fetoprotein (AFP), normal human chorionic gonadot
ropin (HCG), and elevated lactate dehydrogenase (LDH) levels, a small
prechemotherapy or postchemotherapy mass, and a large shrinkage of the
mass during chemotherapy. Multivariate combination of predictors yiel
ded reliable models (goodness-of-fit tests, P > .20), which discrimina
ted necrosis well from other histologies (area under the receiver oper
ating characteristics (ROC) curve, .84), but which discriminated cance
r only reasonably from mature teratoma (area, .66). Internal and exter
nal validation confirmed these findings. Conclusion: The validated mod
els estimated with high accuracy the histology at resection, especiall
y necrosis, based on well-known and readily available predictors. The
predicted probabilities may help to chose between immediate resection
of a residual mass or follow-up, taking into account the expected bene
fits and risks of resection, feasibility of frequent follow-up, the fo
llow-up, the financial costs, and the patient's individual preferences
.